NDC Package 82243-1001-1 Focinvez

Fosaprepitant Injection Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
82243-1001-1
Package Description:
1 VIAL, SINGLE-DOSE in 1 CARTON / 50 mL in 1 VIAL, SINGLE-DOSE
Product Code:
Proprietary Name:
Focinvez
Non-Proprietary Name:
Fosaprepitant
Substance Name:
Fosaprepitant Dimeglumine
Usage Information:
Fosaprepitant is used with other medications to help prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). Fosaprepitant works by blocking one of the body's natural substances (substance P/neurokinin 1) that causes vomiting. This medication will not treat nausea or vomiting that has already started. Ask your doctor what you should do if you already have nausea or vomiting.
11-Digit NDC Billing Format:
82243100101
NDC to RxNorm Crosswalk:
  • RxCUI: 2664065 - fosaprepitant 150 MG in 50 ML Injection
  • RxCUI: 2664065 - 50 ML fosaprepitant 3 MG/ML Injection
  • RxCUI: 2664065 - fosaprepitant 150 MG per 50 ML Injection
  • RxCUI: 2664071 - FOCINVEZ 150 MG in 50 ML Injection
  • RxCUI: 2664071 - 50 ML fosaprepitant 3 MG/ML Injection [Focinvez]
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Spes Pharmaceuticals Inc.
    Dosage Form:
    Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Sample Package:
    No
    FDA Application Number:
    NDA216686
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    08-30-2023
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 82243-1001-1?

    The NDC Packaged Code 82243-1001-1 is assigned to a package of 1 vial, single-dose in 1 carton / 50 ml in 1 vial, single-dose of Focinvez, a human prescription drug labeled by Spes Pharmaceuticals Inc.. The product's dosage form is injection and is administered via intravenous form.

    Is NDC 82243-1001 included in the NDC Directory?

    Yes, Focinvez with product code 82243-1001 is active and included in the NDC Directory. The product was first marketed by Spes Pharmaceuticals Inc. on August 30, 2023 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 82243-1001-1?

    The 11-digit format is 82243100101. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-182243-1001-15-4-282243-1001-01